Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART II—Surgical Evaluation and Treatment. Issue 4 (13th October 2021)

• Record Type: Journal Article
• Authors: Lerner, Lori B.; McVary, Kevin T.; Barry, Michael J.; Bixler, Brooke R.; Dahm, Philipp; Das, Anurag Kumar; Gandhi, Manhar C.; Kaplan, Steven A.; Kohler, Tobias S.; Martin, Leslie; Parsons, J. Kellogg; Roehrborn, Claus G.; Stoffel, John T.; Welliver, Charles; Wilt, Timothy J.
• Is Part Of: Journal of urology. Volume 206:Issue 4(2021)
• Page Start: 818
• Page End: 826
• Publication Date: 2021-10-13
• Subjects: Prostate surgery -- LUTS -- BPH -- TURP -- TUIP -- TUVP -- HoLEP -- ThuLEP -- PVP -- aquablation -- PUL -- TUMT -- MIST -- water vapor thermal therapy -- robotic assisted simple prostatectomy -- open prostatectomy -- simple prostatectomy; Genitourinary organs -- Periodicals; Urology -- Periodicals; Urology -- Periodicals; Urologie -- Périodiques; Urologie; 616.6
• DOI: 10.1097/JU.0000000000002184
• Languages: English
• ISSNs: 0022-5347

Abstract

Abstract : Purpose: Surgical therapies for symptomatic bladder outlet obstruction (BOO) due to benign prostatic hyperplasia (BPH) are many, and vary from minimally invasive office based to high-cost operative approaches. This Guideline presents effective evidence-based surgical management of male lower urinary tract symptoms secondary/attributed to BPH (LUTS/BPH). See accompanying algorithm for a detailed summary of procedures (figure ). Materials/Methods: The Minnesota Evidence Review Team searched Ovid MEDLINE, Embase, Cochrane Library, and AHRQ databases to identify eligible studies published between January 2007 and September 2020, which includes the initial publication (2018) and amendments (2019, 2020). The Team also reviewed articles identified by Guideline Panel Members. When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low) for support of Strong, Moderate, or Conditional Recommendations. In the absence of sufficient evidence, information is provided as Clinical Principles and Expert Opinions (table ). Results: Twenty-four guideline statements pertinent to pre-operative and surgical management were developed. Appropriate levels of evidence and supporting text were created to direct urologic providers towards suitable and safe operative interventions for individual patient characteristics. A re-treatment section was created to direct attention to longevity and outcomes with individual approaches to help guide patient counselling and therapeutic decisions. Conclusion: Pre-operative and surgical management of BPH requires attention to individual patient characteristics and procedural risk. Clinicians should adhere to recommendations and familiarize themselves with criteria that yields the highest likelihood of surgical success when choosing a particular approach for a particular patient.